Glorioso 2005.

Trial name or title	NCT 00245206 ID: R01MH71536
Methods	Allocation: random, no further details Blindness: open label. Duration: 5 years Design: parallel. Location: unclear.
Participants	Diagnosis: schizophrenia. Age ≥ 45 years. Gender: male/female participants. History: duration of illness not reported. Setting: not reported.
Interventions	1. Aripiprazole. 2. Olanzapine. 3. Risperidone. 4. Quetiapine.
Outcomes	Metabolic, cardiovascular and cerebrovascular effects.
Starting date	August 2005.
Contact information	University of California
Notes